Cargando…
Update on Viral Gene Therapy Clinical Trials for Retinal Diseases
In 2001, the first large animal was successfully treated with a gene therapy that restored its vision. Lancelot, the Briard dog that was treated, suffered from a human childhood blindness called Leber's congenital amaurosis type 2. Sixteen years later, the gene therapy was approved by the U.S....
Autores principales: | Cheng, Shun-Yun, Punzo, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639220/ https://www.ncbi.nlm.nih.gov/pubmed/36074935 http://dx.doi.org/10.1089/hum.2022.159 |
Ejemplares similares
-
Loss of the cone-enriched caspase-7 does not affect secondary cone death in retinitis pigmentosa
por: Venkatesh, Aditya, et al.
Publicado: (2017) -
Advances in Gene Therapy for Diseases of the Eye
por: Petit, Lolita, et al.
Publicado: (2016) -
An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials
por: Chiu, Wei, et al.
Publicado: (2021) -
Update on Clinical Trials in Retinal Diseases
por: Kozak, Igor
Publicado: (2016) -
Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases
por: Kansara, Viral, et al.
Publicado: (2020)